Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600131318) titled 'The mechanism of hepatic arterial perfusion chemotherapy affecting the efficacy of immune checkpoint inhibitors in the treatment of advanced hepatocellular carcinoma' on Sept. 1.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: Fudan University Shanghai Cancer Center
Condition:
Advanced Hepatocellular Carcinoma
Intervention:
Patients with aHCC who underwent surgical resection:None
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2025-08-01
Target Sample Size: Patients with aHCC who underwent surgical resection:116;Patients with aHCC receiving HAIC c...